Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Prior status of graft-versus-host disease affects donor lymphocyte infusion outcomes in patients with relapsed haematological malignancies after allogeneic stem cell transplantation.
Journal: British journal of haematology
Published: January 11, 2025
Sensitivity and Specificity of Chimerism Tests in Predicting Leukemia Relapse Using Increasing Mixed Chimerism.
Journal: The Journal of molecular diagnostics : JMD
Published: April 17, 2024
Impact of post-transplant cyclophosphamide and splenomegaly on primary graft failure and multi-lineage cytopenia after allogeneic hematopoietic cell transplantation.
Journal: Leukemia research
Published: February 12, 2024
Implementing a behavioral physical activity program in children and adolescent survivors of childhood cancer: a pilot randomized controlled trial.
Journal: Journal of behavioral medicine
Published: December 05, 2023
Assessment of chimerism by next generation sequencing: A comparison to STR/qPCR methods.
Journal: Human immunology
Published: April 18, 2023
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.
Journal: Annals of hematology
Published: September 15, 2022
Low-dose total body irradiation promotes T-cells donor chimerism in reduced-intensity/non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide.
Journal: Leukemia research
Published: August 09, 2022
Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.
Journal: Neuro-oncology
Published: February 11, 2022
Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
Journal: Transplantation and cellular therapy
Published: November 21, 2021
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion.
Journal: Annals of hematology
Published: January 25, 2021
Last Updated: 09/26/2026